News

Filter

Current filters:

None

7860 to 7869 of 97217 results

Positive Ph IV data for Pfizer and UCB's Toviaz

06-08-2012

Global drugs behemoth Pfizer (NYSE: PFE) has released positive Phase IV study results assessing the efficacy…

Genito-urinaryPfizerPharmaceuticalResearchToviazUCB

UK NICE draft guidance backs Servier's Procoralan for chronic heart failure

06-08-2012

The UK's drugs watchdog the National Institute for Health and Clinical Excellence (NICE), in draft guidance…

Cardio-vascularEuropePharmaceuticalPricingProcoralanRegulationServier

New Zealand moves to forming national hospital medicines list

06-08-2012

New Zealand's national pharmaceuticals funding agency, PHARMAC, says it has begun a significant step…

Asia-PacificHealthcarePharmaceutical

Zaltrap gains US approval for metastatic colorectal cancer

06-08-2012

The US Food and Drug Administration on Friday approved French drug major Sanofi (Euronext: SAN) and US…

North AmericaOncologyPharmaceuticalRegeneronRegulationSanofiZaltrap

UK govt and pharma industry to start drug pricing negations next month

06-08-2012

The Association of the British Pharmaceutical Industry (ABPI) and the UK Department of Health (DoH) on…

BiotechnologyEuropePharmaceuticalPricing

XOMA and Servier sign manufacturing deal with Boehringer for gevokizumab

06-08-2012

US therapeutic antibody discovery firm XOMA Corp (Nasdaq: XOMA) its partner France's Laboratoires Servier…

Boehringer IngelheimgevokizumabLicensingOphthalmicsPharmaceuticalProductionServierXOMA Corp

7860 to 7869 of 97217 results

Back to top